Quarterly ResultMay 14, 2026, 04:19 PM
INNOVATE Corp. Q1 Revenue +33% to $364.8M; Adj. EBITDA +174%
AI Summary
INNOVATE Corp. announced strong first quarter 2026 results, with consolidated revenue increasing 33.0% to $364.8 million and Total Adjusted EBITDA surging 173.6% to $19.7 million. The company significantly reduced its net loss attributable to common stockholders by 30.6% to $17.2 million. Key drivers included robust performance in the Infrastructure segment and a major regulatory approval for MediBeacon in Life Sciences, partially offset by declines in the Spectrum segment.
Key Highlights
- Consolidated revenue increased 33.0% to $364.8 million from $274.2 million year-over-year.
- Net loss attributable to common stockholders improved 30.6% to $17.2 million from $24.8 million.
- Total Adjusted EBITDA grew 173.6% to $19.7 million from $7.2 million year-over-year.
- Infrastructure segment revenue rose 35.1% to $357.9 million, with Adjusted EBITDA of $23.0 million.
- MediBeacon received CE mark for its Transdermal GFR Monitor and Reusable Sensor in Europe.
- Life Sciences Adjusted EBITDA losses improved by $6.7 million to $2.0 million.
- Spectrum segment revenue decreased to $5.3 million, with Adjusted EBITDA of $0.7 million.
- Cash and cash equivalents stood at $134.6 million as of March 31, 2026.